A recent study reveals that patients who discontinue new slimming jabs like Wegovy and Mounjaro may regain lost weight far faster than those who halt traditional lifestyle regimens.
Findings released in a major medical journal points out that while overweight people frequently drop substantial amounts of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"Users purchasing such medications must be informed of the danger of rapid rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
Such speed of recovery means a reversion to starting weight within about 18 months.
Comparing Therapies
The research, which examined 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who shed pounds through diet and exercise generally have a less rapid weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists believe the mechanism of the injections is key to understanding the amplified regain.
The injections copy a natural hormone called GLP-1, which moderates appetite.
"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making overeating much more probable."
A Lifelong Condition?
Medical guidelines suggest the injections for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Many experts say that, considering the likelihood of relapse, the treatment should be considered life-long.
This opinion is supported by drug manufacturers, who note that the findings "emphasize the long-term character of excess weight," similar to managing diseases like hypertension.
User Testimonies
Individuals who have come off the jabs explain a powerful return of cravings.
"I experienced something activating and I was suddenly extremely hungry," recalled an individual.
This difficulty is compounded if users have not established sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Figures suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is more common among women than males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while the jabs are potent agents for weight loss, they are not a magic fix and maintained weight loss relies on integrated behavioural support.
